What is the ROE (Return on Equity) of Cann Group this year?
The ROE of Cann Group this year is -3.68 undefined.
Cann Group ROE 2024
Cann Group ROE
-3.68
Ticker
CAN.AX
ISIN
AU000000CAN2
WKN
A2DSUQ
In 2024, Cann Group's return on equity (ROE) was -3.68, a 1,080.75% increase from the -0.31 ROE in the previous year.
Cann Group Aktienanalyse
What does Cann Group do?
Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients. Cann Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Cann Group's Return on Equity (ROE)
Cann Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Cann Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Cann Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Cann Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Cann Group stock
How has the Return on Equity (ROE) of Cann Group developed compared to the previous year?
The ROE of Cann Group has increased by 1,080.75% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Cann Group?
A high ROE indicates that Cann Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Cann Group?
A low ROE can indicate that Cann Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Cann Group affect the company?
A change in ROE (Return on Equity) of Cann Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Cann Group?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Cann Group?
Some factors that can influence Cann Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Cann Group pay?
Over the past 12 months, Cann Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cann Group is expected to pay a dividend of 0 AUD.
What is the dividend yield of Cann Group?
The current dividend yield of Cann Group is .
When does Cann Group pay dividends?
Cann Group pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cann Group?
Cann Group paid dividends every year for the past 0 years.
What is the dividend of Cann Group?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cann Group located?
Cann Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cann Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cann Group from 10/4/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Cann Group pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Cann Group in the year 2023?
In the year 2023, Cann Group distributed 0 AUD as dividends.
In which currency does Cann Group pay out the dividend?
The dividends of Cann Group are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cann Group
Our stock analysis for Cann Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
